NMC Health (LON:NMC) had its price objective upped by Barclays from GBX 4,100 ($53.57) to GBX 4,275 ($55.86) in a research report report published on Friday, Digital Look reports. They currently have an overweight rating on the stock.
A number of other equities analysts have also commented on NMC. Jefferies Financial Group reduced their price target on shares of NMC Health from GBX 2,077 ($27.14) to GBX 1,986 ($25.95) and set an underperform rating on the stock in a research report on Tuesday, July 9th. Berenberg Bank restated a buy rating and issued a GBX 3,600 ($47.04) price target on shares of NMC Health in a research report on Tuesday, May 28th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company. The stock has an average rating of Buy and a consensus price target of GBX 3,793.50 ($49.57).
LON NMC opened at GBX 1,910 ($24.96) on Friday. The company has a market capitalization of $3.99 billion and a PE ratio of 16.08. The company has a 50-day simple moving average of GBX 2,341.44. NMC Health has a twelve month low of GBX 1,915.50 ($25.03) and a twelve month high of GBX 4,376 ($57.18). The company has a debt-to-equity ratio of 150.61, a quick ratio of 1.16 and a current ratio of 1.45.
About NMC Health
NMC Health Plc provides healthcare services in the United Arab Emirates, Spain, and internationally. The company operates through two businesses, NMC Healthcare and NMC Trading. It owns and manages approximately 135 healthcare facilities that include hospitals, medical centers, long term care facilities, day surgery centers, fertility centers, and home health services providers.
See Also: Book Value Per Share in Stock Trading
Receive News & Ratings for NMC Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NMC Health and related companies with MarketBeat.com's FREE daily email newsletter.